Ontology highlight
ABSTRACT:
ORGANISM(S): Homo sapiens
SUBMITTER: Edward Parkinson
PROVIDER: E-MTAB-15687 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress

Trials 20200415 1
<h4>Background</h4>Vancomycin has been used in clinical practice for over 50 years; however, validated, pharmacokinetic (PK) data relating clinical outcomes to different dosing regimens in neonates are lacking. Coagulase negative staphylococci (CoNS) are the most commonly isolated organisms in neonatal, late-onset sepsis (LOS). Optimised use to maximise efficacy while minimising toxicity and resistance selection is imperative to ensure vancomycin's continued efficacy.<h4>Methods</h4>NeoVanc is a ...[more]